Dr. Souzan Sanati, MD

Dr. Sanati practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Sanati's NPI, 1922149863, was assigned on February 12, 2007. Dr. Sanati graduated from Iran University of Medical Sciences in 1993. Dr. Sanati's California license number on file is C137975.

Dr. Sanati's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Sanati's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Dr. Sanati is also affiliated with Cedars-Sinai Marina Hospital. The medical group on file is Cedars-Sinai Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sanati practices, 2 sites in all. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Dr. Sanati's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dr. Sanati is board certified in cytopathology by the American Board of Pathology. Dmand AI has Dr. Sanati's licenses on file in 3 states: California, Illinois and Missouri.

CMS data shows 2,116 Medicare services from Dr. Sanati across 17 procedure codes in 2024, for 759 Medicare patients. Medicare paid $71,412 for them.

CMS counts 759 Medicare patients who saw Dr. Sanati in 2024. The largest group is 65 to 74, with 327 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sanati's median patient age at 55, with 67% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Sanati for performance year 2024, reported as part of a group. Dr. Sanati accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 30 papers to Dr. Sanati, published from 2015 to 2025. 2017 was the busiest year, with 9. The most frequent topics are Breast Neoplasms, Neoadjuvant Therapy and Antineoplastic Combined Chemotherapy Protocols. Dr. Sanati has published most often in Mod Pathol. Dr. Sanati's most frequent co-authors are Matthew J. Ellis, MD, PhD, Julie A. Margenthaler, MD and Foluso Olabisi Ademuyiwa, MD.

Dmand AI links Dr. Sanati to 4 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Triple Negative Breast Neoplasms. Washington University School of Medicine sponsors the most, 4.

CMS Open Payments shows 9 general payments to Dr. Sanati from 3 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 98% of the total. Eli Lilly and Company paid the most, $38,276.

Dr. Sanati graduated from Iran University of Medical Sciences in 1993.

Dr. Sanati is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.